Literature DB >> 14611880

Immunostimulant principles from Curculigo orchioides.

V Lakshmi1, K Pandey, Anju Puri, R P Saxena, K C Saxena.   

Abstract

Curculigo orchioides Gaerten belongs to the family Amaryllidaceae. The rhizomes of the plants are used for the treatment of decline in strength, jaundice and asthma. Its methanolic extract has been shown to enhance phagocytic activity of macrophages. Present studies have led to the isolation of two phenolic glycosides and a purified glycoside fraction. These were studied for their effect on macrophage migration index (MMI), haemagglutination (HA) titre, plaque forming cell (PFC), PHA-induced blast transformation of lymphocytes (BTL) and delayed type hypersensitivity (DTH). Significant immunostimulant activity was found in purified glycoside-rich fraction isolated from the ethyl acetate extract. The exact structure of the active glycoside is yet to be determined. The enhancement of HA titre and PFC count on one hand and that of DTH response on the other indicates that glycoside fraction stimulates both humoral and Cell-mediated immune responses. Glycoside fraction stimulates immune response by acting both on macrophages and the lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611880     DOI: 10.1016/s0378-8741(03)00160-0

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  12 in total

1.  Curculigoside facilitates fear extinction and prevents depression-like behaviors in a mouse learned helplessness model through increasing hippocampal BDNF.

Authors:  San-Juan Yang; Zhu-Jin Song; Xun-Cui Wang; Zheng-Rong Zhang; Sheng-Bing Wu; Guo-Qi Zhu
Journal:  Acta Pharmacol Sin       Date:  2019-04-26       Impact factor: 6.150

2.  Curculigo orchioides Gaertn Effectively Ameliorates the Uro- and Nephrotoxicities Induced by Cyclophosphamide Administration in Experimental Animals.

Authors:  Vishnu Priya Murali; Girija Kuttan
Journal:  Integr Cancer Ther       Date:  2015-09-29       Impact factor: 3.279

3.  Analysis of a Major Phenolic Glucoside and Biochemistry Compounds from Curculigo Orchioides Gaertn.

Authors:  Thanh Pham; Nu Ngoc Doan Huyen Phan; Van Giang Tran; Thi Quynh Nguyen; Minh Duc Tran; Thanh Hung Nguyen
Journal:  Rep Biochem Mol Biol       Date:  2022-01

4.  Chinese herbal medicine for osteoporosis: a systematic review of randomized controlled trails.

Authors:  Zhi-Qian Wang; Jin-Long Li; Yue-Li Sun; Min Yao; Jie Gao; Zhu Yang; Qi Shi; Xue-Jun Cui; Yong-Jun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-30       Impact factor: 2.629

5.  Protective effects of Tualang honey on bone structure in experimental postmenopausal rats.

Authors:  Siti Sarah Mohamad Zaid; Siti Amrah Sulaiman; Nor Hayati Othman; Ima-Nirwana Soelaiman; Ahmad Nazrun Shuid; Norazlina Mohamad; Norliza Muhamad
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

6.  Effects of Curculigoside on Memory Impairment and Bone Loss via Anti-Oxidative Character in APP/PS1 Mutated Transgenic Mice.

Authors:  Lu Zhao; Sha Liu; Yin Wang; Qiaoyan Zhang; Wenjuan Zhao; Zejian Wang; Ming Yin
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

7.  The protective effect of Epimedii Folium and Curculiginis Rhizoma on Alzheimer's disease by the inhibitions of NF-κB/MAPK pathway and NLRP3 inflammasome.

Authors:  Zhou Lan; Guangjing Xie; Meng Wei; Ping Wang; Lvyi Chen
Journal:  Oncotarget       Date:  2017-07-04

8.  Ameliorative effects of curculigoside from Curculigo orchioides Gaertn on learning and memory in aged rats.

Authors:  Xiu-Ying Wu; Jian-Zhong Li; Jian-Zheng Guo; Bao-Yuan Hou
Journal:  Molecules       Date:  2012-08-24       Impact factor: 4.411

Review 9.  Phytochemistry and Pharmacological Activity of Plants of Genus Curculigo: An Updated Review Since 2013.

Authors:  Ying Wang; Junlong Li; Ning Li
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

Review 10.  Awareness and Current Therapeutics of Asthma.

Authors:  Rida Zainab; Muhammad Akram; Muhammad Daniyal; Muhammad Riaz
Journal:  Dose Response       Date:  2019-09-04       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.